Health Catalyst (HCAT) Stock: Buy, Sell, or Hold?
HCAT - Health Catalyst, Inc Common Stock
$1.70
-0.03 (-1.73%)
âŧ
5d:
-0.58%
30d:
-5.03%
90d:
+3.66%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When HCAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: HCAT is fairly priced but lacks strong directional signals. At 104.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: HCAT is fairly priced but lacks strong directional signals. At 104.3% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: HCAT is currently trading at $1.70, which is considered fair relative to its 30-day fair value range of $1.54 to $1.96. From a valuation perspective, the stock is trading at a premium (Forward PE: 215.2) compared to its historical average (25.2). At these levels, the market is pricing in 104.3% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, HCAT is in a downtrend. Immediate support is located at $1.55, while resistance sits at $1.77.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HCAT is in a downtrend. Immediate support is located at $1.55, while resistance sits at $1.77.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.54 -
$1.96
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
Protect Your Profits
Holding HCAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($1.82)
- BEARISH: Market expects 104.3% growth - appears too optimistic based on history
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.54 -
$1.96
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.55
Resistance Level
$1.77
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
215.19
Wall Street Target
$1.83
(+7.4%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-90.6%
Valuation Premium vs History
+104.3% premium
PE vs Historical
215.2 vs 25.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+104.3%
(market-implied from PE analysis)
1-Year Target
$2.55
(+50%)
2-Year Target
$3.83
(+125%)
3-Year Target
$5.74
(+238%)
3-Yr Target (if PE normalizes)
(PE: 215â25)
PE COMPRESSION
$0.67
(-61%)
Significant PE compression expected
Share & Embed Analysis
Last updated: September 12, 2026 3:20 AM ET
Data refreshes hourly during market hours. Next update: 4:20 AM
Data refreshes hourly during market hours. Next update: 4:20 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 39 SELL |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 42 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
WAY
Waystar Holding Corp. CoâĻ |
STRONG BUY
13 analysts |
$33 | 45 HOLD |
Advanced HCAT Option Strategies
Professional options setups generated by AI based on today's HCAT price and gamma walls.
